Dodecafluoro-3H-4,8-dioxanoate (NaDONA)

"Forever chemicals" have become a household worry, but most testing focuses on the older, well-studied ones. This test looks for a newer replacement compound that industry adopted to sidestep the growing scrutiny of the originals.

A urine result here is a snapshot of recent exposure. In the general population this chemical is almost never detected, so a positive result is a meaningful signal that something in your environment, most likely your water, has put it into your body.

What This Chemical Actually Is

NaDONA (sodium dodecafluoro-3H-4,8-dioxanonanoate), also called ADONA (which in the published literature usually refers to the ammonium salt of the same acid, ammonium 4,8-dioxa-3H-perfluorononanoate), belongs to a large group of synthetic compounds known as PFAS (per- and polyfluoroalkyl substances). These are prized in manufacturing because they resist heat, water, and grease, and that same durability is why they linger in the environment and in the body.

NaDONA is one of a handful of "ether-PFAS" alternatives brought in to replace legacy chemicals like PFOA and PFOS. It is measured mostly as a way to track environmental and human exposure, alongside similar replacements such as GenX and F-53B.

How Rarely It Shows Up in People

The most direct human data comes from large exposure surveys, and they suggest background exposure is uncommon. In a US national health survey (NHANES, which measures chemicals in a representative sample of the population), this chemical was not detected in any of 2,682 archived urine samples from people aged 6 and older.

Exposure can still happen in specific settings. In plasma samples from blood donors in South Germany, near a region with a known fluorochemical source, it was detectable in only a few of nearly 400 samples, and only at trace levels just above the lab's detection limit. In a US community studied for exposure through the Cape Fear River, this class of newer ether-PFAS was largely undetectable in blood, which researchers linked to residents switching to bottled water months earlier and to these compounds leaving the body relatively quickly.

What the Health Evidence Does and Doesn't Show

This is a research-stage marker, not an established clinical test. The available human evidence measures whether the chemical is present, not whether a given level predicts any disease. There are no standardized reference ranges and no studies linking a urine level of this specific compound to health outcomes in people.

The broader PFAS family has been studied for possible links to kidney, thyroid, and cholesterol effects, but those findings come from other, mostly older PFAS compounds and cannot be assumed to apply to this newer chemical. In fact, early laboratory data suggest this compound may disrupt the thyroid less than PFOA or GenX. Treat a result here as an exposure signal to investigate, not a diagnosis.

Why Urine Reflects Recent Exposure

Newer ether-PFAS like this one are expected to have short half-lives, meaning the body clears them comparatively fast and eliminates them in urine. That can make urine a window into recent contact rather than a record of years of buildup.

There is an important caveat: the same national survey that found no detectable levels concluded that urine may not be a reliable way to biomonitor these fast-clearing alternatives in the general population, since low detection can reflect genuinely low exposure as much as rapid clearance. Timing is the other limitation. Because the compound washes out quickly, a sample taken well after an exposure event may read clean even if you were exposed earlier. Blood testing for these newer compounds has to be done almost immediately after exposure for the same reason.

Why One Reading Is Not Enough

Exposure to this chemical tends to be episodic and tied to a source such as contaminated water, not a steady daily dose. A single test is a moment in time, and because the compound clears fast, one clean result does not rule out intermittent exposure, and one positive result reflects a recent event more than a lasting body burden.

If you have reason to suspect exposure, get a baseline now. If you identify and remove a source, retest in a few months to confirm the level has fallen, and repeat at least annually if you remain in a setting where exposure is possible. Tracking the trajectory tells you far more than any one number, especially for a marker without established cutpoints where your own data is the most useful comparison you have.

Making Sense of an Unexpected Result

If this chemical is detected, the first move is to look for the source, and water is the usual suspect: test your drinking water, and consider whether you live near industrial or fluorochemical activity. Pairing this test with a broader PFAS panel helps clarify whether you are being exposed to a mix of these compounds or just this one.

Given the questions raised about PFAS more broadly, it is reasonable to check kidney function, thyroid function, and cholesterol as companion labs so you have a baseline picture. If exposure appears ongoing or occupational, a toxicology or occupational-medicine specialist can help interpret the pattern and guide next steps.

When a Single Reading Can Mislead

• Urine dilution: how much water you drank before the sample can concentrate or dilute the reading. Results are usually adjusted using urine creatinine (a waste product used to correct for dilution), and without that correction a value can look artificially high or low.
• Timing after exposure: because this compound clears the body quickly, a sample collected days after an exposure can read clean even when you were genuinely exposed. A negative result is not proof you have never encountered it.
• Assay differences: these newer compounds are measured with specialized, sensitive lab methods, and detection limits vary between labs. A "not detected" result means below that lab's threshold, not necessarily zero.